Mitochondrial complex II and reactive oxygen species in disease and therapy

Increasing evidence points to the respiratory Complex II (CII) as a source and modulator of reactive oxygen species (ROS). Both functional loss of CII as well as its pharmacological inhibition can lead to ROS generation in cells, with a relevant impact on the development of pathophysiological condit...

Full description

Bibliographic Details
Main Authors: Katerina Hadrava Vanova, Michal Kraus, Jiri Neuzil, Jakub Rohlena
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:Redox Report
Subjects:
Online Access:http://dx.doi.org/10.1080/13510002.2020.1752002
_version_ 1818665487844769792
author Katerina Hadrava Vanova
Michal Kraus
Jiri Neuzil
Jakub Rohlena
author_facet Katerina Hadrava Vanova
Michal Kraus
Jiri Neuzil
Jakub Rohlena
author_sort Katerina Hadrava Vanova
collection DOAJ
description Increasing evidence points to the respiratory Complex II (CII) as a source and modulator of reactive oxygen species (ROS). Both functional loss of CII as well as its pharmacological inhibition can lead to ROS generation in cells, with a relevant impact on the development of pathophysiological conditions, i.e. cancer and neurodegenerative diseases. While the basic framework of CII involvement in ROS production has been defined, the fine details still await clarification. It is important to resolve these aspects to fully understand the role of CII in pathology and to explore its therapeutic potential in cancer and other diseases.
first_indexed 2024-12-17T05:49:25Z
format Article
id doaj.art-67b2efa0763044b29ab37ab24fcd3cd6
institution Directory Open Access Journal
issn 1351-0002
1743-2928
language English
last_indexed 2024-12-17T05:49:25Z
publishDate 2020-01-01
publisher Taylor & Francis Group
record_format Article
series Redox Report
spelling doaj.art-67b2efa0763044b29ab37ab24fcd3cd62022-12-21T22:01:12ZengTaylor & Francis GroupRedox Report1351-00021743-29282020-01-01251263210.1080/13510002.2020.17520021752002Mitochondrial complex II and reactive oxygen species in disease and therapyKaterina Hadrava Vanova0Michal Kraus1Jiri Neuzil2Jakub Rohlena3Institute of Biotechnology of the Czech Academy of SciencesInstitute of Biotechnology of the Czech Academy of SciencesInstitute of Biotechnology of the Czech Academy of SciencesInstitute of Biotechnology of the Czech Academy of SciencesIncreasing evidence points to the respiratory Complex II (CII) as a source and modulator of reactive oxygen species (ROS). Both functional loss of CII as well as its pharmacological inhibition can lead to ROS generation in cells, with a relevant impact on the development of pathophysiological conditions, i.e. cancer and neurodegenerative diseases. While the basic framework of CII involvement in ROS production has been defined, the fine details still await clarification. It is important to resolve these aspects to fully understand the role of CII in pathology and to explore its therapeutic potential in cancer and other diseases.http://dx.doi.org/10.1080/13510002.2020.1752002respiratory complex iisuccinate dehydrogenasereactive oxygen speciesoxphosmitochondriacancersuccinatetricarboxylic acid cycle
spellingShingle Katerina Hadrava Vanova
Michal Kraus
Jiri Neuzil
Jakub Rohlena
Mitochondrial complex II and reactive oxygen species in disease and therapy
Redox Report
respiratory complex ii
succinate dehydrogenase
reactive oxygen species
oxphos
mitochondria
cancer
succinate
tricarboxylic acid cycle
title Mitochondrial complex II and reactive oxygen species in disease and therapy
title_full Mitochondrial complex II and reactive oxygen species in disease and therapy
title_fullStr Mitochondrial complex II and reactive oxygen species in disease and therapy
title_full_unstemmed Mitochondrial complex II and reactive oxygen species in disease and therapy
title_short Mitochondrial complex II and reactive oxygen species in disease and therapy
title_sort mitochondrial complex ii and reactive oxygen species in disease and therapy
topic respiratory complex ii
succinate dehydrogenase
reactive oxygen species
oxphos
mitochondria
cancer
succinate
tricarboxylic acid cycle
url http://dx.doi.org/10.1080/13510002.2020.1752002
work_keys_str_mv AT katerinahadravavanova mitochondrialcomplexiiandreactiveoxygenspeciesindiseaseandtherapy
AT michalkraus mitochondrialcomplexiiandreactiveoxygenspeciesindiseaseandtherapy
AT jirineuzil mitochondrialcomplexiiandreactiveoxygenspeciesindiseaseandtherapy
AT jakubrohlena mitochondrialcomplexiiandreactiveoxygenspeciesindiseaseandtherapy